AVENIO Tumor Tissue Surveillance Kit V2
Product TypeAssay Kit
TechnologyNext-Generation Sequencing
Regulatory StatusRUO
Key takeaways
AVENIO Tumor Tissue Surveillance Kit V2 is a product in the Sequencing & Genomics category, manufactured by Roche Diagnostics. Listed regulatory status: RUO (as reported by the manufacturer).
- Platform: Next-Generation Sequencing
- Applications: Oncology Markers

Classification
- Category
- Sequencing & Genomics
- Product Type
- Assay Kit
- Technology
- Next-Generation Sequencing
Application
- Application Area
- Oncology Markers
Regulatory Status
RUO
Reported from manufacturer sources and not independently verified.
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
Designed for longitudinal monitoring of tumor burden, the AVENIO Tumor Tissue Surveillance Kit V2 is an NGS research use only assay that complements the AVENIO ctDNA by establishing a baseline from formalin-fixed paraffin-embedded (FFPE) tissue samples.
Others AVENIO Tumor Tissue Surveillance Kit V2 RUO AVENIO Tumor Tissue Surveillance Kit V2 PID00000593 The AVENIO Tumor Tissue Analysis Kits V2 include the reagents needed to isolate DNA from formalin-fixed paraffin-embeded (FFPE) tissue, prepare sequencing libraries, and enrich selected regions of interest using one of three panel options:AVENIO Tumor Targeted Panel V2(17 genes)AVENIO Tumor…
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-26
2026-10-31
availability varies
